These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11297498)

  • 1. Vitreous concentration of topically applied brimonidine tartrate 0.2%.
    Kent AR; Nussdorf JD; David R; Tyson F; Small D; Fellows D
    Ophthalmology; 2001 Apr; 108(4):784-7. PubMed ID: 11297498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous concentration of topically applied brimonidine-purite 0.15%.
    Kent AR; King L; Bartholomew LR
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):242-6. PubMed ID: 16910864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
    Takamura Y; Tomomatsu T; Matsumura T; Takihara Y; Kozai S; Arimura S; Yokota S; Inatani M
    J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of vitreous prostaglandin E2 levels after topical administration of ketorolac 0.45%.
    Schoenberger SD; Kim SJ; Sheng J; Calcutt MW
    JAMA Ophthalmol; 2014 Feb; 132(2):150-4. PubMed ID: 24264034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship of Brimonidine Concentration in Vitreous Body to the Free Concentration in Retina/Choroid Following Topical Administration in Pigmented Rabbits.
    Shinno K; Kurokawa K; Kozai S; Kawamura A; Inada K; Tokushige H
    Curr Eye Res; 2017 May; 42(5):748-753. PubMed ID: 27854122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes.
    Acheampong AA; Shackleton M; John B; Burke J; Wheeler L; Tang-Liu D
    Drug Metab Dispos; 2002 Apr; 30(4):421-9. PubMed ID: 11901096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study.
    Orii Y; Kunikane E; Yamada Y; Morioka M; Iwasaki K; Arimura S; Mizuno A; Inatani M
    PLoS One; 2022; 17(12):e0277313. PubMed ID: 36454807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-systemic delivery of topical brimonidine to the brain: a neuro-ocular tissue distribution study.
    Abdulrazik M; Tamilvanan S; Benita S
    J Drug Target; 2006 Dec; 14(10):670-9. PubMed ID: 17162736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation effects on ocular absorption of brimonidine in rabbit eyes.
    Acheampong AA; Small D; Baumgarten V; Welty D; Tang-Liu D
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):325-37. PubMed ID: 12222763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
    LeBlanc RP
    Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study.
    Orii Y; Kunikane E; Yamada Y; Morioka M; Iwasaki K; Arimura S; Mizuno A; Inatani M
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of brimonidine concentrations in human plasma by a highly sensitive gas chromatography/mass spectrometric assay.
    Acheampong A; Tang-Liu DD
    J Pharm Biomed Anal; 1995 Jul; 13(8):995-1002. PubMed ID: 8580159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenoceptor agonist poisoning after accidental oral ingestion of brimonidine eye drops.
    Hoffmann U; Kuno S; Franke G; Fusch C; Haas JP
    Pediatr Crit Care Med; 2004 May; 5(3):282-5. PubMed ID: 15115569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
    Larsson LI
    Arch Ophthalmol; 2001 Apr; 119(4):492-5. PubMed ID: 11296014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials.
    Tamhane M; Luu KT; Attar M
    J Pharmacol Exp Ther; 2021 Sep; 378(3):207-214. PubMed ID: 34210753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of brimonidine on aqueous humor dynamics in human eyes.
    Toris CB; Gleason ML; Camras CB; Yablonski ME
    Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
    Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
    Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.
    Konstas AG; Stewart WC; Topouzis F; Tersis I; Holmes KT; Stangos NT
    Am J Ophthalmol; 2001 Jun; 131(6):729-33. PubMed ID: 11384568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of brimonidine tartrate on ocular hemodynamic measurements.
    Lachkar Y; Migdal C; Dhanjil S
    Arch Ophthalmol; 1998 Dec; 116(12):1591-4. PubMed ID: 9869786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review.
    Saylor M; McLoon LK; Harrison AR; Lee MS
    Arch Ophthalmol; 2009 Apr; 127(4):402-6. PubMed ID: 19365015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.